Investing in AngioDynamics, Inc. (ANGO)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)6.360
Intrinsic value (DCF)12.6498
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

ANGO, also known as AngioDynamics Inc., is a medical technology company that specializes in the development, manufacturing, and marketing of minimally invasive medical devices used in the treatment of various diseases and disorders. The company's primary focus is on vascular interventions, which involve the diagnosis and treatment of blockages in the human circulatory system. AngioDynamics' products include catheters, ports, drainage systems, and other medical devices that are used in the treatment of conditions such as deep vein thrombosis, peripheral arterial disease, and cancer. With a strong track record of innovation and technological advancement, ANGO continues to provide healthcare professionals with state-of-the-art solutions for improving patient outcomes. Headquartered in Latham, New York, ANGO has a global presence with operations in the United States, Europe, and Asia. The company also collaborates with leading medical institutions to develop groundbreaking therapies and expand its product portfolio. ANGO's commitment to improving patient care and its relentless pursuit of new technologies make it a leader in the medical device industry.